Use of Recombinant Hyaluronidase Human is Effective for the Use of Local Blocks for Eyelid's Surgery

• Status: Withdrawn
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the use of recombinant hyaluronidase (rHuPH20) as an adjunctive for local anaesthesia, lidocaine 2% with epinephrine 1:100000, for eyelid surgery.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Duke University
• Treatments: Epinephrine; Epinephryl borate; Lidocaine; Racepinephrine

Criteria

• Inclusion Criteria:

• Capable and willing to provide consent

• Has been scheduled for bilateral upper eyelid surgery

• At least 18 years of age

• Exclusion Criteria:

• Unable or unwilling to give consent

• Previous upper eyelid surgery

• Under 18 years of age